FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:212-213 January 16, 1997 Number 3 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Coronary-artery bypass grafting (CABG) has been performed for more than 30 years. After the first bypass operation with a saphenous-vein graft, in 1964,¹ the technique was formally described in 1967²; one year later the use of a graft from the internal thoracic artery was initiated. Revascularization with CABG was complemented in 1977 by the technique of percutaneous transluminal coronary angioplasty (PTCA). These revascularization methods have profound economic implications; approximately 1 million patients undergo revascularization in the United States each year, at an estimated cost exceeding $15 billion.³

CABG, the most commonly performed major operation in the United States, effectively . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Pokrovsky, S. N., Ezhov, M. V., Il'ina, L. N., Afanasieva, O. I., Sinitsyn, V. Y., Shiriaev, A. A., Akchurin, R. S. (2003). Association of lipoprotein(a) excess with early vein graft occlusions in middle-aged men undergoing coronary artery bypass surgery. J. Thorac. Cardiovasc. Surg. 126: 1071-1075 [Abstract] [Full Text]  
• Avila, P. C., Campeau, L., Knatterud, G. L., Domanski, M., Hunninghake, D. B., The Post Coronary Artery Bypass Graft Trial Invest, (1997). Prevention of Atherosclerosis in Coronary-Artery Bypass Grafts. NEJM 336: 1839-1840 [Full Text]  
• (1997). Aggressive Cholesterol Lowering Benefits the Post-Bypass Patient. Journal Watch Cardiology 1997: 2-2 [Full Text]